ASTRAZEN.BOASTRAZEN.BOBSE
Loading
EBITDA Over TimeContracting
Percentile Rank93
3Y CAGR+25.1%
5Y CAGR+8.2%
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

3Y CAGR
+25.1%/yr
vs +19.6%/yr prior
5Y CAGR
+8.2%/yr
Recent acceleration
Acceleration
+5.5pp
Accelerating
Percentile
P93
Near historical high
vs 5Y Ago
1.5x
Solid growth
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
2025$1.98B-16.1%
2024$2.36B+56.1%
2023$1.51B+49.6%
2022$1.01B-31.8%
2021$1.48B+10.7%
2020$1.34B+52.6%
2019$875.90M+77.7%
2018$492.80M+8.4%
2017$454.50M+164.3%
2016$171.99M-